Visicol maker calls kidney failure reports misleading
Salix Pharmaceuticals is calling a recent report linking its bowel prep drug to kidney failure misleading. Consumer advocacy group Public Citizen had cited a study in the Journal of the American Society of Nephrology calling bowel-cleansing products containing sodium phosphate an ?underrecognized? cause of chronic kidney failure.
Visicol maker calls kidney failure reports misleading
Salix Pharmaceuticals is calling a recent report linking its bowel prep drug to kidney failure misleading. Consumer advocacy group Public Citizen had cited a study in the Journal of the American Society of Nephrology calling bowel-cleansing products containing sodium phosphate an “underrecognized” cause of chronic kidney failure. Salix’s executive director of medical affairs said the report did not clarify that of the 21 cases of kidney failure, only one could be attributed to Visicol, while the other 20 were caused by Fleet Phospho-Soda. He also stated that the one affected Visicol patient was at increased risk because he had underlying renal dysfunction, was taking an ACE inhibitor, and was not properly hydrated.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
Challenges for Pharmacies in 2025: What to Expect and How to Prepare
January 8th 2025Pharmacy professionals are used to overcoming obstacles in this competitive, dynamic field. But the coming year will bring challenges affecting patient care, the industry workforce and their business. Pharmacies must be ready to do more than weather the storm; they need deliberate strategy and sophisticated tools to thrive amidst these obstacles. This white paper will discuss the issues and solutions that should be at the top of every pharmacy professional’s mind as they start the new year.
